Most bought by hedge funds
41.84k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stocks that were bought the most by hedge funds in the last quarter.
Curated by Yahoo Finance
Follow this list to discover and track the stocks that were bought the most by hedge funds in the last quarter.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Most bought by hedge funds | +2.89% | - | - | - |
| ^GSPC | +0.63% | +1.84% | +21.28% | +5752.15% |
31 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| BAC | Bank of America Corporation | 39.265 | +0.51 | +1.30% | 11:03 am GMT-4 | 6.55M | 39.85M | 304.68B |
| WFC | Wells Fargo & Company | 54.56 | +0.56 | +1.04% | 11:02 am GMT-4 | 3.03M | 17.21M | 185.71B |
| PFE | Pfizer Inc. | 29.165 | +0.61 | +2.12% | 11:03 am GMT-4 | 10.11M | 31.95M | 165.27B |
| T | AT&T Inc. | 21.165 | +0.20 | +0.93% | 11:03 am GMT-4 | 10.58M | 33.84M | 151.76B |
| UBER | Uber Technologies, Inc. | 70.13 | +0.55 | +0.79% | 11:03 am GMT-4 | 2.72M | 15.49M | 147.34B |
| BMY | Bristol-Myers Squibb Company | 48.655 | -0.05 | -0.09% | 11:02 am GMT-4 | 2.23M | 14.94M | 98.64B |
| APH | Amphenol Corporation | 60.235 | +0.39 | +0.64% | 11:03 am GMT-4 | 2.01M | 7.34M | 72.54B |
| NU | Nu Holdings Ltd. | 13.9001 | +0.20 | +1.46% | 11:03 am GMT-4 | 8.45M | 42.41M | 66.57B |
| KVUE | Kenvue Inc. | 22.98 | +0.12 | +0.52% | 11:03 am GMT-4 | 2.99M | 18.00M | 44.01B |
| CPNG | Coupang, Inc. | 22.5 | +0.50 | +2.27% | 11:02 am GMT-4 | 1.09M | 7.17M | 40.36B |
| BBD | Banco Bradesco S.A. | 2.82 | +0.01 | +0.36% | 11:02 am GMT-4 | 5.55M | 22.59M | 28.65B |
| HPE | Hewlett Packard Enterprise Company | 17.68 | +0.15 | +0.86% | 11:03 am GMT-4 | 2.91M | 14.41M | 22.96B |
| TEVA | Teva Pharmaceutical Industries Limited | 17.995 | -0.08 | -0.47% | 11:02 am GMT-4 | 1.83M | 8.99M | 21.35B |
| CCL | Carnival Corporation & plc | 15.985 | +0.31 | +2.01% | 11:03 am GMT-4 | 5.43M | 28.14M | 20.94B |
| DT | Dynatrace, Inc. | 50.61 | +0.43 | +0.86% | 11:02 am GMT-4 | 797.65k | 3.13M | 15.08B |
| SNAP | Snap Inc. | 8.59 | -0.03 | -0.35% | 11:03 am GMT-4 | 5.03M | 22.70M | 14.25B |
| SMMT | Summit Therapeutics Inc. | 19.435 | +7.16 | +58.39% | 11:03 am GMT-4 | 25.79M | 2.17M | 14.08B |
| VIK | Viking Holdings Ltd | 32.22 | -0.17 | -0.52% | 11:02 am GMT-4 | 237.09k | 1.47M | 13.91B |
| PR | Permian Resources Corporation | 13.19 | -0.06 | -0.45% | 11:03 am GMT-4 | 1.50M | 10.48M | 10.59B |
| EDR | Endeavor Group Holdings, Inc. | 27.515 | +0.08 | +0.31% | 11:01 am GMT-4 | 5.31M | 3.25M | 8.44B |
| SWN | Southwestern Energy Company | 6.025 | -0.01 | -0.25% | 11:03 am GMT-4 | 4.72M | 18.86M | 6.65B |
| LOAR | Loar Holdings Inc. | 69.325 | +0.85 | +1.25% | 11:01 am GMT-4 | 38.12k | 272.33k | 6.22B |
| ALIT | Alight, Inc. | 7.255 | +0.10 | +1.33% | 11:02 am GMT-4 | 501.39k | 5.08M | 4.04B |
| NYCB | New York Community Bancorp, Inc. | 10.68 | -0.13 | -1.20% | 11:03 am GMT-4 | 2.64M | 6.49M | 3.98B |
| WULF | TeraWulf Inc. | 3.7888 | +0.06 | +1.71% | 11:03 am GMT-4 | 4.98M | 21.83M | 1.45B |
| TELL | Tellurian Inc. | 0.9127 | -0.01 | -0.79% | 11:02 am GMT-4 | 15.98M | 45.39M | 815.84M |
| ELYM | Eliem Therapeutics, Inc. | 8.0799 | +0.69 | +9.34% | 11:01 am GMT-4 | 191.27k | 237.51k | 541.84M |
| PIII | P3 Health Partners Inc. | 0.5092 | +0.05 | +10.80% | 11:02 am GMT-4 | 231.87k | 329.14k | 282.24M |
| BDSX | Biodesix, Inc. | 1.825 | -0.02 | -1.35% | 11:02 am GMT-4 | 14.65k | 147.66k | 264.95M |
| CNTX | Context Therapeutics Inc. | 2.23 | -0.09 | -3.88% | 10:56 am GMT-4 | 34.66k | 236.94k | 167.25M |
- Yahoo Finance Video
Merck stock reacts to Summit cancer drug outdoing Keytruda
Merck & Co. (MRK) shares are in the red in Monday's pre-market trading after a study found Summit Therapeutics' (SMMT) lung cancer treatment drug ivonescimab to show better results than Merck's Keytruda. Seana Smith and Brad Smith break down this news. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
Investor's Business DailyMerck Dives After Summit — Up 66% — Sneaks In With Keytruda-Walloping Punch
Merck stock tumbled Monday after Summit Therapeutics' cancer drug outperformed blockbuster Keytruda in a study of lung cancer patients.
InvestopediaLung Cancer Drug Trial News Has Summit Therapeutics Stock Up 40% Today
Summit Therapeutics reported positive results from a Phase 3 trial in China of its lung cancer treatment ivonescimab.
